Podcasts about EHR

Dr. John Sweetenham and Dr. Erika Hamilton highlight key abstracts that were presented at ASCO25, including advances in breast and pancreatic cancers as well as remarkable data from the use of structured exercise programs in cancer care. Transcript Dr. Sweetenham: Hello, and welcome to the ASCO Daily News Podcast. I'm your host, Dr. John Sweetenham. Today, we'll be discussing some of the key advances and novel approaches in cancer care that were presented at the 2025 ASCO Annual Meeting. I'm delighted to be joined again by the chair of the Meeting's Scientific Program, Dr. Erika Hamilton. She is a medical oncologist and director of breast cancer and gynecologic cancer research at the Sarah Cannon Research Institute in Nashville, Tennessee.  Our full disclosures are available in the transcript of this episode. Dr. Hamilton, congratulations on a fantastic meeting. From the practice-changing science to the world-renowned speakers at this year's Meeting, ASCO25 really reflected the amazing progress we're seeing in oncology today and the enormous opportunities that lie ahead of us. And thanks for coming back on to the podcast today to discuss some of these advances. Dr. Hamilton: Thanks, Dr. Sweetenham. I'm happy to join you today. It really was an impactful ASCO Annual Meeting. I probably am biased, but some great research was presented this year, and I heard lots of great conversations happening while we were there. Dr. Sweetenham: Yeah, absolutely. There was a lot of buzz, as well as a lot of media buzz around the meeting this year, and I think that's probably a good place to start. So I'd like to dive into abstract number LBA3510. This was the CHALLENGE trial, which created a lot of buzz at the meeting and subsequently in the media. This is the study that was led by the NCI Canada Clinical Trials Group, which was the first randomized phase 3 trial in patients with stage III and high-risk stage II colon cancer, which demonstrated that a post-treatment structured exercise program is both feasible and effective in improving disease-free survival in this patient group. The study was performed over a long period of time and in many respects is quite remarkable. So, I wonder if you could give us your thoughts about this study and whether you think that this means that our futures are going to be full of structured exercise programs for those patients who may benefit. Dr. Hamilton: It's a fantastic question. I think that this abstract did create a lot of buzz. We were very excited when we read it. It was highlighted in one of the Clinical Science Symposium sessions. But briefly, this was a phase 3 randomized trial. It was conducted at 55 centers, so really a broad experience, and patients that had resected colon cancer who completed adjuvant therapy were allowed to participate. There were essentially 2 groups: a structured exercise program, called ‘the exercise group,' or health education materials alone, so that was called just ‘the health education group.' And this was a 3-year intervention, so very high quality. The primary end point, as you mentioned, was disease-free survival. This actually accrued from 2009 to 2024, so quite a lift, and almost 900 patients underwent randomization to the exercise group or the health education group. And at almost 8 years of follow-up, we saw that the disease-free survival was significantly longer in the exercise group than the health education group. This was essentially 80.3% of patients were disease-free in exercise and 73.9% in the health education group. So a difference of over 6 percentage points, which, you know, at least in the breast cancer world, we make decisions about whether to do chemotherapy or not based on these kind of data. We also looked at overall survival in the exercise group and health education group, and the 8-year overall survival was 90.3% in the exercise group and 83.2% in the health education group. So this was a difference of 7.1%. Still statistically significant. I think this was really a fantastic effort over more than a decade at over 50 institutions with almost 900 patients, really done in a very systematic, high-intervention way that showed a fantastic result. Absolutely generalizable for patients with colon cancer. We have hints in other cancers that this is beneficial, and frankly, for our patients for other comorbidities, such as cardiovascular, etc., I really think that this is an abstract that deserved the press that it received. Dr. Sweetenham: Yeah, absolutely, and it is going to be very interesting, I think, over the next 2 or 3 years to see how much impact this particular study might have on programs across the country and across the world actually, in terms of what they do in this kind of adjuvant setting for structured exercise. Dr. Hamilton: Absolutely.  So let's move on to Abstract 3006. This was an NCI-led effort comparing genomic testing using ctDNA and tissue from patients with less common cancers who were enrolled in but not eligible for a treatment arm of the NCI-MATCH trial. Tell us about your takeaways from this study. Dr. Sweetenham: Yeah, so I thought this was a really interesting study based, as you said, on NCI-MATCH. And many of the listeners will probably remember that the original NCI-MATCH study screened almost 6,000 patients to assess eligibility for those who had an actionable mutation. And it turned out that about 60% of the patients who went on to the study had less common tumors, which were defined as anything other than colon, rectum, breast, non–small cell lung cancer, or prostate cancer. And most of those patients lacked an eligible mutation of interest and so didn't get onto a trial therapy. But with a great deal of foresight, the study group had actually collected plasma samples from these patients so that they would have the opportunity to look at circulating tumor DNA profiles with the potential being that this might be another way for testing for clinically relevant mutations in some of these less common cancer types. So initially, they tested more than 2,000 patients, and to make a somewhat complicated story short, there was a subset of five histologies with a larger representation in terms of sample size. And these were cholangiocarcinoma, small cell lung cancer, esophageal cancer, pancreatic, and salivary gland cancer. And in those particular tumors, when they compared the ctDNA sequencing with the original tumor, there was a concordance there of around 84%, 85%. And in the presentation, the investigators go on to list the specific mutated genes that were identified in each of those tumors. But I think that the other compelling part of this study from my perspective was not just that concordance, which suggests that there's an opportunity there for the use of ctDNA instead of tumor biopsies in some of these situations, but what was also interesting was the fact that there were several clinically relevant mutations which were detected only in the circulating tumor DNA. And a couple of examples of those included IDH1 for cholangiocarcinoma, BRAF and p53 in several histologies, and microsatellite instability was most prevalent in small cell lung cancer in the ctDNA. So I think that what this demonstrates is that liquid biopsy is certainly a viable screening option for patients who are being assessed for matching for targeted therapies in clinical trials. The fact that some of these mutations were only seen in the ctDNA and not in the primary tumor specimen certainly suggests that there's some tumor heterogeneity. But I think that for me, the most compelling part of this study was the fact that many of these mutations were only picked up in the plasma. And so, as the authors concluded, they believe that a comprehensive gene profiling with circulating tumor DNA probably should be included as a primary screening modality in future trials of targeted therapy of this type. Dr. Hamilton: Yeah, I think that that's really interesting and mirrors a lot of data that we've been seeing. At least in breast cancer, you know, we still do a biopsy up front to make sure that our markers, we're still treating the right disease that we think we are. But it really speaks to the utility of using ctDNA for serial monitoring and the emergence of mutations. Dr. Sweetenham: Absolutely. And you mentioned breast cancer, and so I'd like to dwell on that for a moment here because obviously, there was a huge amount of exciting breast cancer data presented at the meeting this year. And in particular, I'd like to ask you about LBA1008, the DESTINY-Breast09 clinical trial, which I think has the potential to establish a new first-line standard of care for metastatic HER2+ breast cancer. And that's an area where we haven't seen a whole lot of innovation for around a decade now. So can you give us some of the highlights of this trial and what your thinking is, having seen the results? Dr. Hamilton: Yeah, absolutely. So this was a trial in the first-line metastatic HER2 setting. So this was looking at trastuzumab deruxtecan. We certainly have had no shortage of reports around this drug, initially approved for later lines. DESTINY-Breast03 brought it into our second-line setting for HER2+ disease and we're now looking at DESTINY-Breast09 in first-line. So this actually was a 3-arm trial where patients were randomized 1:1:1 against standard taxane/trastuzumab/pertuzumab in one arm; trastuzumab deruxtecan with pertuzumab in another arm; and then a third arm, trastuzumab deruxtecan alone. And what we did not see reported was that trastuzumab deruxtecan-alone arm. But we did have reports from the trastuzumab deruxtecan plus pertuzumab versus the chemo/trastuzumab/pertuzumab. And what we saw was a statistically significant improvement in median progression-free survival, 26.9 months up to 40.7, so an improvement of 13.8 months, over a year in PFS. Not to mention that we're now in the 40-month range for PFS in first-line disease. Really, across all subgroups, we really weren't able to pick out a subset of patients that did not benefit. We did see about a 12% ILD rate with trastuzumab deruxtecan. That really is on par with what we've seen in other studies, around 10%-15%. I think that this is going to become a new standard of care in the first-line. I think it did leave some unanswered questions. We saw some data from the PATINA trial this past San Antonio Breast, looking at the addition of endocrine therapy with or without a CDK4/6 inhibitor, palbociclib, for those patients that also have ER+ disease, after taxane has dropped out in the first-line setting. So how we're going to kind of merge all this together is, I suspect that there are going to be patients that we or they just don't have the appetite to continue 3 to 4 years of trastuzumab deruxtecan. And so we're probably going to be looking at a maintenance-type strategy for them, maybe integrating the PATINA data there. But how we really put this into practice in the first-line setting and if or when we think about de-escalating down from trastuzumab deruxtecan to antibody therapy are some lingering questions. Dr. Sweetenham: Okay, so certainly is going to influence practice, but watch this space for a little bit longer, it sounds as though that's what you're saying. Dr. Hamilton: Absolutely.  So let's move on to GI cancer. Abstract 4006 reported preliminary results from the randomized phase 2 study of elraglusib in combination with gemcitabine/nab-paclitaxel versus the chemo gemcitabine/nab-paclitaxel alone in patients with previously untreated metastatic pancreatic cancer. Can you tell us more about this study? Dr. Sweetenham: Yeah, absolutely. As you mentioned, elraglusib is actually a first-in-class inhibitor of GSK3-beta, which has multiple potential actions in pancreatic cancer. But the drug itself may be involved in mediating drug resistance as well as in some tumor immune response modulation. Some of that's not clearly understood, I believe, right now. But certainly, preclinical data suggests that the drug may be effective in preclinical models and may also be effective in combination with chemotherapy and potentially with immune-modulating agents as well. So this particular study, as you said, was an open-label, randomized phase 2 study in which patients with pancreatic cancer were randomized 2:1 in favor of the elraglusib plus GMP—gemcitabine and nab-paclitaxel—versus the chemotherapy alone. And upon completion of the study, which is not right now, median overall survival was the primary end point, but there are a number of other end points which I'll talk about in just a moment. But the sample size was planned to be around 207 patients. The primary analysis included 155 patients in the combination arm versus 78 patients in the gemcitabine/nab-paclitaxel arm. Overall, the 1-year overall survival rate was 44.1% for the patients in the elraglusib-containing arm versus 23.0% in the patients receiving gemcitabine/nab-paclitaxel only. When they look at the median overall survival, it was 9.3 months for the experimental arm versus 7.2 months for chemotherapy alone. So put another way, there's around a 37% reduction in the risk of death with the use of this combination arm. The treatment was overall well-tolerated. There were some issues with grade 1 to 2 transient visual impairment in a large proportion of the patients. The most common treatment-related adverse effects with the elraglusib/GMP combination was transient visual impairment, which affected around 60% of the patients. Most of the more serious treatment-related adverse events included neutropenia, anemia, and fatigue in 50%, 25%, and 16% of the patients, respectively. So the early results from this study show a significant benefit for 1-year overall survival and for median overall survival with, as I mentioned above, a significant reduction in the risk of death. The authors went on to mention that the median overall survival for the control arm in this study is somewhat lower than in other comparable trials, but they think that this may be related to a more advanced disease burden in this particular study. Of interest to me was that right now: there is no apparent difference in progression-free survival between the 2 arms of this study. The authors described this as potentially indicating that this may be related in some way to immune modulation and immune effects on the tumor, which, if I'm completely honest, I don't totally understand. And so, the improvement in overall survival, as far as I can see at the moment, is not matched by an improvement in progression-free survival. So I think we probably need to wait for more time to elapse to see what happens with the study. And so, I think it certainly is an interesting study, and the results are intriguing, but I think it's probably a little early for it to actually shift the treatment paradigm in this disease. Dr. Hamilton: Fantastic. I think we've been waiting for advances in pancreatic cancer for a long time, but this, not unlike others, we learn more and then learn more we don't realize, so. Dr. Sweetenham: Right. Let's shift gears at this point and talk about a couple of other abstracts in kind of a very different space. Let's start out with symptom management for older adults with cancer. We know that undertreated symptoms are common among the older patient population, and Abstract 11002 reported on a randomized trial that demonstrated the effects of remote monitoring for older patients with cancer in terms of kind of symptoms and so on. Can you tell us a little bit about this study and whether you think this approach will potentially improve care for older patients? Dr. Hamilton: Yeah, I really liked this abstract. It was conducted through the Veterans Affairs, and it was based in California, which I'm telling you that because it's going to have a little bit of an implication later on. But essentially, adults that were 75 years or older who were Medicare Advantage beneficiaries were eligible to participate. Forty-three clinics in Southern California and Arizona, and patients were randomized either into a control group of usual clinic care alone, or an intervention group, which was usual care plus a lay health worker-led proactive telephone-based weekly symptom assessment, and this was for 12 months using the validated Edmonton Symptom Assessment System. So, there was a planned enrollment of at least 200 patients in each group. They successfully met that. And this lay health worker reviewed assessments with a physician assistant, who conducted follow-up for symptoms that changed by 2 points from a prior assessment or were rated 4 or greater. So almost a triage system to figure out who needed to be reached out to and to kind of work on symptoms. What I thought was fantastic about this was it was very representative of where it enrolled. There were actually about 50% of patients enrolled here that were Hispanic or Latinos. So some of our underserved populations and really across a wide variety of tumor types. They found that the intervention group had 53% lower odds of emergency room use, 68% lower odds of hospital use than the control group. And when they translated this to actual total cost of care, this was a savings of about $12,000 U.S. per participant and 75% lower odds of a death in an acute care facility. So I thought this was really interesting for a variety of reasons. One, certainly health care utilization and cost, but even more so, I think any of our patients would want to prevent hospitalizations and ER visits. Normally, that's not a fantastic experience having to feel poorly enough that you're in the emergency room or the hospital. And really showing in kind of concrete metrics that we were able to decrease this with this intervention. In terms of sustainability and scalability, I think the question is really the workforce to do this. Obviously, you know, this is going to take dedicated employees to have the ability to reach out to these patients, etc., but I think in value-based care, there's definitely a possibility of having reimbursement and having the funds to institute a program like this. So, definitely thought-provoking, and I hope it leads to more interventions. Dr. Sweetenham: Yeah, we've seen, over several years now, many of these studies which have looked at remote symptom monitoring and so on in this patient population, and many of them do show benefits for that in kinds of end points, not the least in this study being hospitalization and emergency room avoidance. But I think the scalability and personnel issue is a huge one, and I do wonder at some level whether we may see some AI-based platforms coming along that could actually help with this and provide interactions with these patients outside of actual real people, or at least in combination with real people. Dr. Hamilton: Yeah, that's a fantastic point.  So let's talk a little bit about clinical trials. So eligibility assessment for oncology clinical trials, or prescreening, really relies on manual review of unstructured clinical notes. It's time-consuming, it's prone to errors, and Abstract 1508 reported on the final analysis of a randomized trial that looked at the effect of human-AI teams prescreening for clinical trial eligibility versus human-only or AI-only prescreening. So give us more good news about AI. What did the study find? Dr. Sweetenham: Yeah, this is a really, a really interesting study. And of course, any of us who have ever been involved in clinical trials will know that accrual is always a problem. And I think most centers have attempted, and some quite successfully managed to develop prescreening programs so that patients are screened by a health care provider or health care worker prior to being seen in the clinic, and the clinical investigator will then already know whether they're going to be eligible for a trial or not. But as you've already said, it's a slow process. It's typically somewhat inefficient and requires a lot of time on the part of the health care workers to actually do this in a successful way. And so, this was a study from Emory University where they took three models of ways in which they could assess the accuracy of the prescreening of charts for patients who are going to be considered for clinical trials. One of these was essentially the regular way of having two research coordinators physically abstract the charts. The second one was an AI platform which would extract longitudinal EHR data. And then the third one was a combination of the two. So the AI would be augmented by the research coordinator or the other way around. As a gold standard, they had three independent oncology reviewers who went through all of these charts to provide what they regarded as being the benchmark for accuracy. In a way, it's not a surprise to me because I think that a number of other systems which have used this combination of human verification of AI-based tools, it actually ultimately concluded that the combination of the two in terms of chart accuracy was for the most part better than either one individually, either the research coordinator or the AI alone. So I'll give you just a few examples of where specifically that mattered. The human plus AI platform was more accurate in terms of tumor staging, in terms of identifying biomarker testing and biomarker results, as well as biomarker interpretation, and was also superior in terms of listing medications. There are one or two other areas where either the AI alone was somewhat more accurate, but the significant differences were very much in favor of a combination of human + AI screening of these patient charts. So, in full disclosure, this didn't save time, but what the authors reported was that there were definite efficiency gains, and presumably this would actually become even more improved once the research coordinators were somewhat more comfortable and at home with the AI tool. So, I thought it was an interesting way of trying to enhance clinical trial accrual up front by this combination of humans and technology, and I think it's going to be interesting to see if this gets adopted at other centers in the future. Dr. Hamilton: Yeah, I think it's really fascinating, all the different places that we can be using AI, and I love the takeaway that AI and humans together are better than either individually. Dr. Sweetenham: Absolutely.  Thanks once again, Dr. Hamilton, for sharing your insights with us today and for all of the incredible work you did to build a robust program. And also, congratulations on what was, I think, a really remarkable ASCO this year, one of the most exciting for some time, I think. So thank you again for that. Dr. Hamilton: Thanks so much. It was really a pleasure to work on ASCO 2025 this year. Dr. Sweetenham: And thank you to our listeners for joining us today. You'll find links to all the abstracts we discussed today in the transcript of this episode. Be sure to catch up on all of our coverage from the Annual Meeting. You can catch up on my daily reports that were published each day of the Annual Meeting, featuring the key science and innovations presented. And we'll have wrap-up episodes publishing in June, covering the full spectrum of malignancies from ASCO25. If you value the insights you hear on the ASCO Daily News Podcast, please remember to rate, review, and subscribe wherever you get your podcasts. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.   More on today's speakers: Dr. John Sweetenham   Dr. Erika Hamilton @erikahamilton9   Follow ASCO on social media:  @ASCO on Twitter  ASCO on Bluesky  ASCO on Facebook   ASCO on LinkedIn     Disclosures:     Dr. John Sweetenham:     No relationships to disclose    Dr. Erika Hamilton: Consulting or Advisory Role (Inst): Pfizer, Genentech/Roche, Lilly, Daiichi Sankyo, Mersana, AstraZeneca, Novartis, Ellipses Pharma, Olema Pharmaceuticals, Stemline Therapeutics, Tubulis, Verascity Science, Theratechnologies, Accutar Biotechnology, Entos, Fosun Pharma, Gilead Sciences, Jazz Pharmaceuticals, Medical Pharma Services, Hosun Pharma, Zentalis Pharmaceuticals, Jefferies, Tempus Labs, Arvinas, Circle Pharma, Janssen, Johnson and Johnson   Research Funding (Inst): AstraZeneca, Hutchison MediPharma, OncoMed, MedImmune, Stem CentRx, Genentech/Roche, Curis, Verastem, Zymeworks, Syndax, Lycera, Rgenix, Novartis, Millenium, TapImmune, Inc., Lilly, Pfizer, Lilly, Pfizer, Tesaro, Boehringer Ingelheim, H3 Biomedicine, Radius Health, Acerta Pharma, Macrogenics, Abbvie, Immunomedics, Fujifilm, eFFECTOR Therapeutics, Merus, Nucana, Regeneron, Leap Therapeutics, Taiho Pharmaceuticals, EMD Serono, Daiichi Sankyo, ArQule, Syros Pharmaceuticals, Clovis Oncology, CytomX Therapeutics, InventisBio, Deciphera, Sermonix Pharmaceuticals, Zenith Epigentics, Arvinas, Harpoon, Black Diamond, Orinove, Molecular Templates, Seattle Genetics, Compugen, GI Therapeutics, Karyopharm Therapeutics, Dana-Farber Cancer Hospital, Shattuck Labs, PharmaMar, Olema Pharmaceuticals, Immunogen, Plexxikon, Amgen, Akesobio Australia, ADC Therapeutics, AtlasMedx, Aravive, Ellipses Pharma, Incyte, MabSpace Biosciences, ORIC Pharmaceuticals, Pieris Pharmaceuticals, Pieris Pharmaceuticals, Pionyr, Repetoire Immune Medicines, Treadwell Therapeutics, Accutar Biotech, Artios, Bliss Biopharmaceutical, Cascadian Therapeutics, Dantari, Duality Biologics, Elucida Oncology, Infinity Pharmaceuticals, Relay Therapeutics, Tolmar, Torque, BeiGene, Context Therapeutics, K-Group Beta, Kind Pharmaceuticals, Loxo Oncology, Oncothyreon, Orum Therapeutics, Prelude Therapeutics, Profound Bio, Cullinan Oncology, Bristol-Myers Squib, Eisai, Fochon Pharmaceuticals, Gilead Sciences, Inspirna, Myriad Genetics, Silverback Therapeutics, Stemline Therapeutics

Dr. Jamie Wells is back—and this time, she brought a book. We cover everything from biomedical design screwups to the glorified billing software known as the EHR. Jamie's new book, A Clinical Lens on Pediatric Engineering, is a masterclass in what happens when you stop treating kids like small, drunk adults and start designing medicine around actual human factors. We talk about AI in pediatric radiology, why drug repurposing might save lives faster than biotech IPOs, and the absurdity of thinking one-size-fits-all in healthcare still works.Jamie's a former physician, a health policy disruptor, a bioethicist, an MIT director, and a recovering adjunct professor. She's also a unicorn. We dig into the wonk, throw shade at bad design, and channel our inner Lisa Simpsons. This one's for anyone who ever wondered why kids' hospitals feel like hell and why “make it taste like bubblegum” might be the most important clinical innovation of all time. You'll laugh, you'll learn, and you might get angry enough to fix something.RELATED LINKSJamie Wells on LinkedInBook: A Clinical Lens on Pediatric Engineering (Amazon)Book on SpringerDrexel BioMed ProfileGlobal Blockchain Business CouncilJamie's HuffPost ArticlesFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Send us a textWhat's the first impression your patients get of your practice? Spoiler alert—it's not your clinical expertise.It's not the credentials on the wall. It's not the sophisticated EHR system you've invested in. It's not even your outcomes data—at least not initially. The first impression starts the moment someone steps through your doors, and it's rooted in an often-overlooked space: your waiting room.Or should I say, what we used to call a waiting room.Today, we're diving into why this space is far more than a holding area. It's your front door of trust, a powerful reflection of how you deliver care—and a golden opportunity to reduce anxiety, elevate patient experience, and even boost the financial health of your practice. If it looks tired or outdated, patients might unconsciously assume your care is, too. If it feels cold and transactional, it primes them to expect the same from your providers. And if it's optimized for comfort, clarity, and calm, it sets the tone for an experience and a relationship grounded in trust.Please Follow or Subscribe to get new episodes delivered to you as soon as they drop! Visit Jill's company, Health e Practices' website: https://healtheps.com/ Subscribe to our newsletter, Health e Connections: http://21978609.hs-sites.com/newletter-subscriber Want more content? Find sample job descriptions, financial tools, templates and much more: www.MedicalMoneyMattersPodcast.com  Purchase your copy of Jill's book here: Physician Heal Thy Financial Self Join our Medical Money Matters Facebook Group here: https://www.facebook.com/groups/3834886643404507/ Original Musical Score by: Craig Addy at https://www.underthepiano.ca/ Visit Craig's website to book your Once in a Lifetime music experience Podcast coaching and development by: Jennifer Furlong, CEO, Communication Twenty-Four Seven https://www.communicationtwentyfourseven.com/

In this expert-led episode, Christopher Rudolf, CEO of Volv Global, unpacks how artificial intelligence is revolutionizing rare disease detection and knowledge generation. With over 30 years in data science and medical informatics, he shares how machine learning is being used to solve two of the biggest challenges in rare disease: finding undiagnosed patients and generating actionable clinical insights.This conversation is essential for professionals in healthcare innovation, data analytics, life sciences, and rare disease advocacy. Discover how AI is shortening diagnostic journeys, overcoming data limitations, and uncovering new phenotypic patterns - especially for ultra-rare conditions often overlooked by traditional systems.In this episode, you will hear:How AI pinpoints hidden rare disease patients using population-scale clinical, claims, and genetic dataWhy traditional EHR data and diagnostic coding fail rare disease detection - and how AI models fill the gapThe challenge of balancing specificity vs. sensitivity in identifying true positivesHow natural history studies and patient-generated data are helping refine precision medicineWhat AI-generated insights reveal that clinical literature often missesThe role of patient advocacy groups in training better algorithms and ensuring relevancePrivacy, redaction, and regulatory concerns - and how to responsibly handle sensitive patient dataThe limitations of synthetic data, federated learning, and digital twins in ultra-rare conditionsHow bias in healthcare data can mislead AI - and what safeguards can mitigate disparitiesWhat's next: scaling ethically, lowering costs, and building trust between AI tools and cliniciansAbout the Podcast:AI for Pharma Growth is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future.This show brings together leading experts and changemakers to demystify AI and show how it's being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI's role in social good, this podcast offers valuable insights.AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget. As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses. This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more. Dr. Andree Bates LinkedIn | Facebook |...

Endocrinologist Michael Morkos discusses his article "Mastering the art of efficient patient encounters: tips for physicians." Michael shares practical strategies for optimizing the patient encounter to enhance both efficiency and patient satisfaction. He delves into effective documentation techniques, emphasizing the importance of maintaining eye contact while touch-typing in the exam room, and adapting clinic setups with adjustable carts and laptops. Michael explains his system for ordering future labs during visits in lab-heavy specialties like endocrinology, ensuring all necessary data is available for follow-up appointments. He also outlines his streamlined EHR workflow, including pre-charting, side-by-side review of outside records, and transparent patient communication during the visit. Michael highlights how these methods enable him to complete all notes and charges by the end of the day, significantly reducing after-hours work and contributing to burnout prevention. Our presenting sponsor is Microsoft Dragon Copilot. Microsoft Dragon Copilot, your AI assistant for clinical workflow, is transforming how clinicians work. Now you can streamline and customize documentation, surface information right at the point of care, and automate tasks with just a click. Part of Microsoft Cloud for Healthcare, Dragon Copilot offers an extensible AI workspace and a single, integrated platform to help unlock new levels of efficiency. Plus, it's backed by a proven track record and decades of clinical expertise—and it's built on a foundation of trust. It's time to ease your administrative burdens and stay focused on what matters most with Dragon Copilot, your AI assistant for clinical workflow. VISIT SPONSOR → https://aka.ms/kevinmd SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

Why does your EHR feel more like a burden than a solution? Eugene Shatsman sits down with leaders from RevolutionEHR, Eyefinity, and practicing ODs to discuss the painful realities of optometric software — and what the next generation must do differently.

June 12, 2025: Jennifer Stemmler, Chief Digital and Information Officer at Adventist Health, opens up about orchestrating one of healthcare's largest EHR migrations—transitioning 28 hospitals and 400 clinics from a decades-old Cerner system to Epic. Guided by the mantra "on time, on budget, on Epic, on us," how does she maintain control without micromanaging every decision? When groups push back on standardization or value-based care teams clash with implementation timelines, what framework actually works to resolve conflicts? Jennifer reveals her benefits realization scorecard approach and discusses the real challenge behind any major transformation: how do you ensure the organization owns the change rather than waiting for someone else to save them? Key Points: 03:09 Strategic Planning and Key Objectives 06:25 Guiding Principles and Pre-Planning Phase 17:44 Managing Internal Tensions and Lessons Learned 25:56 Post-Go-Live Success and Future Planning 34:36 Final Thoughts and Advice for Other Health Systems X: This Week Health LinkedIn: This Week Health Donate: Alex's Lemonade Stand: Foundation for Childhood Cancer

In this episode, Laura Dyrda, Editor-in-Chief at Becker's Healthcare, discusses the latest healthcare stories, including changes to the CDC's vaccine advisory committee, shifts in physician employment trends, and Stanford's pilot of a new AI-powered EHR tool designed to streamline clinician workflows.

In this episode of Quality Matters, Julie Seibert, Assistant Vice President of Behavioral Health at NCQA, joins host Andy Reynolds to explore the rise of—and the relationship between—two trends in behavioral health: measurement-informed care and peer support. Julie breaks down how these strategies improve outcomes, engage patients and close gaps in access and accountability.Listen to this episode to discover: How Measurement-Informed Care Engages Patients: Learn how measurement-informed care supports patient engagement and treatment adjustments in behavioral health. We explore the importance of ongoing assessment, tracking symptoms and outcomes and empowering patients to understand their journey. Friction and Fuel for New Approaches: We unpack historical challenges to measurement-informed care. These include the omission of behavioral health from key legislation and the costs of EHR integration. We also discuss how NCQA depression measures and person-centered outcome measures relate to measurement-informed care.Benefitting From Peers' Lived Experience: We discuss how people who have been through mental health or substance use treatment can provide non-clinical support to help others navigate the system, subvert stigma and fill care gaps.This discussion is a valuable resource for providers, policy leaders and others who care about improving access, engagement and outcomes in behavioral health.Key Quote:"Measurement-based care has been around for a long time and only 20% of behavioral health providers adopted it.Traditionally, these are trained clinicians. And in the course of a session with a patient, probably in the back of their mind, they're evaluating whether an individual is improving or has worsening function.Payers would like some numerical or standardized way of seeing the clinician's clinical judgment. Measurement-informed care offers that."Julie SeibertTime Stamps:(03:04) Who's Behind Measurement-Informed Care(05:08) HEDIS and Measurement-Informed Care(08:13) Person-Centered Outcome Measures in Behavioral Health(09:58) The Power of Peer Support Specialists(11:57) Addressing Workforce Shortages(15:37) Why States Support Peer Support(16:32) Peer Support's Connection to Measurement-Informed CareDive Deeper:Blog: How Peer Support Can Help Close the Gaps in Behavioral HealthcareBlog: Measurement-Based Care in Behavioral HealthQuality Matters Episode 13: Getting Clear About Behavioral HealthConnect with Julie Seibert

In this conversation, Dr. Masoud Nafey shares his unique journey from being an optometrist to becoming a key player in the integration of technology and AI in healthcare. He discusses the challenges and opportunities in building clinics for major corporations, the evolution of electronic health records (EHR), and the potential of AI in transforming patient care. Dr. Nafey emphasizes the importance of understanding customer needs in technology development and explores the complexities of AI, including large language models and the concept of AI hallucinations. He concludes with insights on the future of AI agents in optometry and the necessity of fine-tuning AI systems for specific applications.   -------------------- For our listeners, use the code 'EYECODEMEDIA22' for 10% off at check out for our Premiere Billing & Coding bundle or our EyeCode Billing & Coding course. Sharpen your billing and coding skills today and leave no money on the table! questions@eyecode-education.com https://coopervision.com/our-company/news-center/press-release/coopervision-and-aoa-join-forces-launch-myopia-collective Go to MacuHealth.com and use the coupon code PODCAST2024 at checkout for special discounts  Show Sponsors: CooperVision MacuHealth

The VA is set to resume its electronic health record modernization program in 2026, nearly three years since it was paused in 2023. During the pause, the agency focused on developing a new strategy for deployment to improve success and boost patient safety. VA now plans to jumpstart the program with a focus on functionality and interoperability of the system, Dr. Neil Evans, VA's acting program executive director of VA's Electronic Health Record Modernization Integration Office explains. Evans discusses how this shift in thinking is building the foundation of a stronger, more functional EHR program. He said the EHR rollout will be conducted in “waves,” where geographically connected medical centers will deploy at the same time so that patients who maneuver between them will have their record accessible no matter where they seek care.

The new UI is no UI - How AI is Transforming the EHR and other Core Solutions NextGen Healthcare's CEO David Sides hosts a fascinating conversation with Diane Kaye, chief product officer, and Sanjeev Kumar, PH.D., chief analytics officer. They discuss how the healthtech industry is leveraging AI to remove sources of friction for providers and enable reimagined workflows that lead to better healthcare outcomes for all. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Discover how Mental Health Cooperative (MHC) in Nashville transformed their behavioral health care delivery with the eClinicalWorks 24-hour care module. In this episode, we welcome Megan Isham, Senior Clinical Systems Manager at MHC, who shares their transformative journey and the impact of this tool on their operations. With the growing recognition of behavioral and mental health, it's crucial to understand that delivering mental healthcare involves a broad spectrum of services. From outpatient therapy and counselling to crisis management, detox, and residential programs, each service comes with unique requirements. This podcast dives into how MHC has leveraged these capabilities to enhance their service delivery and improve health outcomes. Megan details how the Behavioral Health (BH) module has streamlined workflows, integrated care episodes, and customized protocols to meet the specific needs of their diverse patient population. She explains how the system's web-based nature allows their field staff to access vital tools in real time, significantly increasing efficiency and care quality. Key highlights include the seamless integration with Pyxis™ for medication management, customizable Progress Notes, and specialized order sets that cater to both inpatient and outpatient needs. Megan also discusses the innovative approaches to patient safety and the efficient management of complex cases through electronic safety plans and real-time census tracking. This episode is packed with valuable insights into how MHC's adoption of the BH module has been a game changer, delivering comprehensive services that truly made a difference.

Dr. Hoyle returns to provide a post-launch update of implementing a collaborative care management model in primary care practice in a large health system. The collaborative model provides continuity of care for chronic conditions such as ADHD, anxiety, and depression. Learn how the care model operates and insights on transforming care practices with a behavioral care manager, data registry, EHR workflows, and billing.

In this episode of the Scope of Things, host Deborah Borfitz brings you the latest news on AI-recommended precision dosing, organoid drug testing aiding treatment selection for bowel cancer, an AI tool for stratifying lung cancer patients, using HIV drugs to treat Alzheimer's disease, and the potential value of magic mushrooms to remedy the mood symptoms of Parkinson's. Blythe Adamson, international head of outcomes research and evidence generation at Flatiron Health, also joins in to discuss groundbreaking work harmonizing patient-level real-world data across four countries to enable multinational oncology research.  News Roundup CURATE.AI platform Article in Clinical Research News Study in npj Precision Oncology   FORECAST-2 clinical trial News on the Walter and Eliza Hall Institute website AI tool for sorting cancer patients Study in Nature Communications  HIV drugs for Alzheimer's protection Study in Alzheimer's & Dementia “Magic mushrooms” for Parkinson's disease Study in Neuropsychopharmacology Guest Blythe Adamson, Ph.D., international head of outcomes research and evidence generation at Flatiron Health  Flatiron Health enabling multinational oncology researh – article in Bio-IT World  Subscribe to the podcast on Apple Podcasts and leave a review to support the show. Join us at Scope Europe on October 14-15 in Barcelona - use code SOT10 for an additional 10% discount. GUEST BIO Blythe Adamson, PhD, MPH, Head of Outcomes Research and Evidence Generation, International at Flatiron Health & Founder of Infectious Economics Dr. Blythe Adamson is the head of international outcomes research and evidence generation at Flatiron Health.   As a visionary senior leader at Flatiron Health, her team pioneered deep learning language models for extraction of clinical details from EHR documents, breaking the limits of what was possible for humans to do alone. Learning from the experience of millions of patients with cancer, they generate evidence of treatment effectiveness and value used by governments around the world. Dr. Adamson co-invented a patented clinical decision-support tool, enabled by machine learning, that is used by cancer clinics to benefit patients.   She holds degrees in microbiology, epidemiology, and pharmaceutical economics with a focus on infectious disease prevention. Dr. Adamson has held roles at the Bill and Melinda Gates Foundation Institute for Disease Modeling, the NIAID HIV Vaccine Trials Network, and Flatiron Health. The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News senior writer, Deborah Borfitz, welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider's look at clinical research today.

In this episode of IDD Health Matters, Dr. Craig Escudé is joined by Ricardo Ortega and Babar Nawaz of iCare Manager—an innovative electronic health record (EHR) company revolutionizing care for people with intellectual and developmental disabilities (IDD). Together, they explore how technology can improve efficiency, documentation, and most importantly, the quality of care delivered by providers across 25 states and counting. Ricardo and Babar share their insights into the unique challenges of healthcare in the IDD field, such as state-specific compliance, staffing shortages, and underfunding. Learn how iCare Manager was built from the ground up—with direct input from DSPs, nurses, coordinators, and executives—to create a one-stop, user-friendly solution that empowers providers to spend more time supporting individuals and less time on paperwork. The conversation also looks ahead to the future of healthcare technology, highlighting the exciting (and sometimes scary!) potential of artificial intelligence (AI) in automating assessments, generating personalized care plans, and enhancing service delivery—all while preserving the vital human touch. Topics include: The origin and mission of iCare Manager Addressing compliance across state systems EHR systems built by providers, for providers How AI can improve outcomes and efficiency The importance of person-centered planning and funding in the IDD space Whether you're a provider, administrator, or simply passionate about inclusive healthcare, this episode offers powerful insight into how technology and compassion can go hand-in-hand to support people with IDD.

AI scribes promise relief from clinical documentation fatigue - but what are their limitations, hidden risks, and true return on investment? In a landscape saturated with new scribing technologies, understanding which tools integrate meaningfully with EHR systems and which merely transcribe surface-level dialogue is critical for healthcare leaders. Hosted by Mika Newton, CEO of xCures (https://www.linkedin.com/in/mikanewton/), this discussion features Dr. Spencer Dorn, Vice Chair and Professor of Medicine at UNC (https://www.linkedin.com/in/spencerdorn/), offering clear insights into how AI scribes impact physician workflow, coding accuracy, and care quality. The conversation examines where current tools fall short, highlights the importance of personalization and contextual summarization, and explores how AI may shift the clinician-patient relationship.

As the nation faces a critical nursing shortage, rural hospitals are often hit hardest. But at Bingham Memorial, Chief Nursing Officer Holly Davis, MBA, BSA, RN, is flipping the script. In this episode, she shares how her team is using EHR-integrated iPhones, streamlining workflows to significantly reduce discharge documentation time by 75%, and putting nurses at the center of decision-making to reduce burnout and boost retention. Discover how a tech-forward, human-first approach is helping empower this Idaho hospital's nursing team.This episode is sponsored by MEDITECH.

The Big Unlock Podcast · Damo Consulting – Podcast – Ep 162 – Priti Patel In this episode, Priti Patel, MD, VP and Chief Medical Information Officer at John Muir Health shares her journey from family physician to CMIO, offering insights into her 23-year tenure and the evolution of clinical informatics. She also talks about key challenges such as change management, the integration of new tools like predictive analytics, and streamlining prior authorization. Dr. Patel discusses the growing role of informatics in healthcare and how collaboration across clinical and IT teams has driven innovation. One of the key highlights at John Muir Health, a community-based health system, is the early adoption of ambient AI technology for clinical documentation, leading to: reduced cognitive load, time savings of up to 30 minutes per note, and enhanced provider-patient interactions. She also emphasizes the critical role of seamless EHR integration in driving adoption, with over 60% of providers now using the tool regularly. Dr. Patel also outlines the organization's enterprise-wide data strategy, including a robust data literacy initiative that's empowering staff at all levels, starting with the C-suite, to make data-driven decisions and improve care quality and operational outcomes. She underscores that aligning digital strategies with organizational priorities—while focusing on improving the clinician and patient experience—is central to sustainable transformation. Take a listen.

For 30 years, Stoltenberg Consulting has been providing consulting services and help desk support to hospitals and clinics. As explained in this interview with Kaitlyn Nelson, Director of Account Solutions and Development, Stoltenberg covers the gamut of support needs: strategic planning, implementation support, optimization, maintenance, training, legacy support, and more.Now, many of these same services are available to health centers in the Federally Qualified Health Center (FQHC) program, through the Boston-based organization, Community Technology Cooperative (CTC). This nonprofit, which currently serves Massachusetts FQHCs but is starting to expand nationally, gives its clients access to Epic's EHR and provides go live and EHR end-user support through a partnership with Stoltenberg. In this interview, Karen Serrago, CIO at CTC, explains this work and how the collaboration with Stoltenberg is making Epic accessible and usable for FQHCs.Learn more about Stoltenberg Consulting: https://www.stoltenberg.com/Learn more about Community Technology Cooperative (CTC): https://communitytechnologycooperative.org/Healthcare IT Community: https://www.healthcareittoday.com/

This week their guest is Walter “Buzz” Stewart, PhD, MPH, is a distinguished healthcare researcher and entrepreneur, currently serving as CEO and Co-Founder of Medcurio, a company specializing in real-time EHR data integration solutions. With a career spanning over three decades, Dr. Stewart has held pivotal roles in both academic and healthcare institutions. He previously led research and development initiatives at Sutter Health and founded the Center for Health Research at Geisinger Health System, focusing on digital health, advanced analytics, and precision medicine. Dr. Stewart's academic tenure includes faculty positions at Johns Hopkins Bloomberg School of Public Health, where he contributed significantly to neuro-epidemiology research. His extensive publication record and leadership in healthcare innovation underscore his commitment to transforming patient care through data-driven strategies. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

With all of the AI implementation into EHR and EMR systems, there is concern about how providers rely on these AI shortcuts more than ever. Without proper safeguards, accountability, and compliance perimeters, relying on AI could be problematic. Terry discusses the red flags to look for and how to proceed with caution in this new […] The post Did you know AI is integrated into EMRs? appeared first on Terry Fletcher Consulting, Inc..

Protecting Revenue With Safety Nets For Timely Filing Epic go-lives and other EHR transitions can be chaotic, high-stakes operations that push revenue cycle teams to the limit. When claim work queues go unattended—even for a few weeks—organizations can lose millions in timely filing denials. On this episode Stuart Newsome, VP of Marketing at Infinx, welcomes Tadd Miller, AR Manager at Ni2, an Infinx company, to share how his team averted disaster during a major Epic implementation by developing practical, real-world safety nets. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Our main focus today was on nudging critical care clinicians to consider a more palliative approach to care.  Our guests are all trained in critical care: Kate Courtright, Scott Halpern, and Jaspal Singh.  Kate and Scott have additional training in palliative medicine.  To start. we review: What is a nudge? Also called behavioral interventions, heuristics, and cognitive biases. Prior podcasts on the ethics of nudging, and a different trial conducted by Kate and Scott in which the default for hospitalized seriously ill patients was to receive a palliative care consult. What is sludge?  I'd never heard the term, perhaps outside of Eric's pejorative reference to my coffee after adding copious creamers, flavoring, and sweeteners.  Sludge is apparently when you create barriers or extra work for someone.  For example, putting the healthy food at the back of the grocery store is sludge; making an applicant for health insurance climb the flight of stairs to the office - weeding out those less fit - is also sludge.  Prior-auth forms? Sludge. Examples of nudges, some based in health care, others in coffee.  This specific study, published in JAMA Internal Medicine, was conducted in 17 ICUs in North Carolina. Many were community hospitals.  Participants were critically ill and intubated.  Clinicians were randomized to 4 groups: Usual care Prognosis nudge - EHR prompt asking, do you think your patient will be alive in 6 months? This is called a focusing effect Comfort care nudge - EHR prompt asking if they'd offered comfort-focused care. This is called accountable justification - an appeal to standards of care for critically ill patients endorsed by multiple professional societies. Both the prognosis and comfort care nudge. A few key points of discussion: Is an EHR prompt a nudge or sludge?   The intervention was a negative study for the primary outcome, hospital length of stay.  Why?  The prognosis nudge did nothing.  What to make of that? Would you think an EHR nudge to consider prognosis might move the needle, at least on some outcomes? The nudge toward offering comfort care led to more hospice and early comfort-care orders.  Is this due to chance alone, given the multiplicity of secondary outcomes examined?  Or is it a tantalizing finding that suggests a remarkably low cost EHR based nudge might, on a population level, lead to critical care clinicians offering comfort care and hospice more frequently?  Imagine!    -Alex Smith  

The ICU Liberation Campaign from the Society of Critical Care Medicine (SCCM) has transformed critical care, but the COVID-19 pandemic and subsequent staffing challenges have posed major obstacles to maintaining progress. In this episode of the SCCM Podcast, host Ludwig H. Lin, MD, speaks with Juliana Barr, MD, FCCM, a key architect of the ICU Liberation Campaign. Dr. Barr was a lead author of the 2013 “Clinical Practice Guidelines for the Management of Pain, Agitation, and Delirium in Adult Patients in the Intensive Care Unit,” known as the PAD guidelines, an original cornerstone of the ICU Liberation Campaign (Barr J, et al. Crit Care Med. 2013;41:263-306). The guidelines' recent 2025 update also addressed immobility and sleep disruption (Lewis K, et al. Crit Care Med. 2025;53:e711-e727). Dr. Barr shares her personal journey from traditional ICU practices of heavy sedation and immobility to leading efforts that prioritize patient recovery, well-being, and post-ICU quality of life. She emphasizes how ICU Liberation reintroduced low-tech, high-impact interventions such as minimizing sedation, promoting early mobility, and engaging families—leading to better outcomes at lower costs. She cites the 2017 international survey by Morandi et al that demonstrated uneven but steady improvements in global ICU Liberation practices before the pandemic (Morandi A, et al. Crit Care Med. 2017;45:e1111-e1122). Dr. Barr details the need for reeducation, multidisciplinary team engagement, and reworking electronic health record (EHR) systems to better support ICU Liberation goals. Looking forward, Dr. Barr offers a "burning platform" approach, stressing that delaying ICU Liberation practices risks poorer patient outcomes. She advocates for cultural change, leadership engagement, real-time metrics visibility, and hospital-wide investment—including IT support to surface buried ICU Liberation Bundle data within EHRs. By reframing ICU Liberation as a "team sport" and making best practices part of daily ICU culture, Dr. Barr believes institutions can reestablish the bundle's momentum and reconnect healthcare teams to their core mission—helping patients return to meaningful lives after critical illness. This conversation offers energizing, practical strategies for ICU teams at every stage of ICU Liberation implementation or reinvigoration.

In this episode of the Becker's Healthcare Podcast, Jakob Emerson speaks with Beata Piehl, Director of Interoperability Solutions and EHR Integrations at Dexcom, about how continuous glucose monitoring (CGM) data is transforming glycemic management through seamless integration with electronic health records. Beata shares the latest innovations in CGM-to-EHR interoperability, how Dexcom supports both individualized care and population health strategies, and what sets their direct integration apart. Tune in to learn how healthcare providers can better leverage CGM data to improve outcomes and operational efficiency.This episode is sponsored by Dexcom.

Healthcare doesn't end at the clinic—and Luke O'Brien of Brook.AI knows that better than most. After navigating care for his father's leukemia, Luke realized just how much support patients and caregivers need after leaving the doctor's office. In this episode, we unpack how Brook.AI built a wraparound solution combining remote monitoring, 24/7 clinical care teams, EHR integration, and operational support—all without adding weight to providers or clinics.

In the second episode of our special series on recommendations to the Trump administration, Quality Matters host Andy Reynolds welcomes Ryan Howells, Principal at Leavitt Partners, for an illuminating discussion on transforming digital quality and data exchange..Ryan shares fresh ideas from the Leavitt Partners roadmap to reshape digital health infrastructure by embracing scalable, internet-based standards and dismantling policy barriers. At the core of this conversation is that effective data exchange must be powered not only by modern standards, but by trust among people and institutions. Ryan's suggestions include:·   Implementing APIs at scale to reduce manual processes and administrative waste. The same APIs that power everyday apps can streamline data exchange between payers and providers, replacing faxes, phone calls and redundant forms.·   Certifying data exchange—not just software functionality. Instead of dictating how systems are built, federal policy should focus on certifying APIs, allowing EHR vendors the flexibility to innovate while helping ensure that data flows freely.·   Establishing “tables of trust.” Regional collaboration among payers, providers and government agencies can test new digital infrastructure in real-world settings and be the model for national expansion.Digital quality transformation will require more than just tech upgrades—we must rethink relationships, trust and policy levers. Listen to this episode to learn how the Trump administration could support a data-driven revolution in health care quality.Key Quote:“I've been doing this for a long time, almost 30 years. But when I go into my doctor's office and I still have to fill out a clipboard with a piece of paper on it with information I know they already have, it is painful. The best representation of whether we are making progress is, I don't want to ever go into a doctor's office and fill out a clipboard. If I could just not fill out my health history, my demographic information, whether information should be sent to my doctor—if all that is just in the doctor's system—I would say we have made progress. Because at that point it will be real to the individual. Think about it in terms of digitizing all of the health care data and making sure it is with the right person, at the right time, in the right place to make the right decisions. When that happens, we'll know we've made significant progress.” Ryan Howells Time Stamps:(02:27) Why Implementing Health Care APIs is Hard(05:32) Tables of Trust: A Case Study from Utah(07:03) Scaling Trust and Interoperability(13:12) Eliminating Manual Processes (18:23) Solving Diverse Use Cases (19:36) Encouraging Early Adoption of APIsLinks:NCQA Recommendations to the Trump Administration Leavitt Partners Recommendations: “Kill the Clipboard!”Connect with Ryan Howells

In this podcast we will discuss lines of defense incorporated into the design, development, implementation, and use of EHRs to ensure their integrity and types of EHR transaction logs (e.g., audit log) that exist.

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to outcomesrocket.com AI partnerships are revolutionizing healthcare by alleviating physician burnout and improving patient care.  In this episode, Pat Williams, CEO of iScribe, and Chad Dodd, Vice President of athenahealth, discuss their partnership and how it is accelerating AI adoption in healthcare. They highlight how iScribe's ambient AI note generation tool, integrated within athenahealth's EHR platform, is reducing documentation time and restoring joy to medical practice. Chad shares results from the 2025 Physician Sentiment Survey, noting a 10% drop in burnout and crediting AI as a key factor, while Pat adds that iScribe users report less EHR time and more same-day encounter rates. Together, they frame this as a pivotal moment for healthcare transformation, with AI enabling better automation, stakeholder collaboration, and improved patient outcomes. Tune in and learn how AI partnerships are transforming healthcare and enhancing the physician-patient experience! Resources: Connect with and follow Pat Williams on LinkedIn. Listen to Pat's previous episode on our podcast here. Follow iScribeHealth on LinkedIn and explore their website. Connect with and follow Chad Dodd on LinkedIn. Follow athenahealth on LinkedIn and explore their website. Listen to Chad's previous episode on our podcast here. Read athenahealth's 2025 Physician Sentiment Survey here.

This episode's Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow' Sustainability Campaign, and how you can get involved: CLICK HEREEpisode Overview: Healthcare's integration challenges have reached a critical juncture where clinicians demand seamless technology that enhances rather than hinders patient care. Our next guest, John Orosco, is revolutionizing this landscape as CEO of Red Rover Health. With over 25 years of healthcare IT experience, including his foundational role at Cerner developing their first API platform, John witnessed firsthand how rigid integration systems stifle innovation. This insight led him to co-found Red Rover Health, creating a normalized SaaS platform that serves as "the App Store for healthcare." By enabling true best-of-breed solutions through standardized APIs, John is breaking down the barriers that have long frustrated healthcare organizations. Join us to discover how Red Rover's pioneering approach is empowering providers to choose the tools they need while maintaining seamless EHR connectivity. Let's go!Episode Highlights:Healthcare's open integration platforms often get shut down when they threaten vendor sales of proprietary solutionsRed Rover Health serves as "the App Store for healthcare," enabling seamless third-party app integration with EHR systemsThe joke "if you've seen one HL7 interface, you've seen one" reflects how every integration requires custom codeHealthcare CIOs often function as "EMR administrators" rather than true technology innovatorsAI/ML represents the next frontier, with Red Rover positioning to enhance data access with AI-powered insightsAbout our Guest: John is a healthcare IT entrepreneur and expert in Electronic Health Record (EHR) integration with over 25 years of experience. He started as a software developer at Cerner Corporation, where he led the first Millennium RESTful integration team. John later founded JASE Health, providing custom EHR integrations for healthcare IT vendors, before co-founding Red Rover Health to develop a normalized SaaS platform for EHR integration. John is dedicated to solving complex EHR challenges and enabling healthcare providers to implement best-of-breed solutions regardless of their EHR system.Links Supporting This Episode: RedRover Health Website: CLICK HEREJohn Orosco LinkedIn page: CLICK HERERed Rover Health LinkedIn: CLICK HEREMike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page: CLICK HEREVisit our website: CLICK HERESubscribe to newsletter: CLICK HEREGuest nomination form: CLICK HERE

In this She Slays Replay, Dr. Brian Capra breaks down a common trap that holds practices back: over-reliance on reports. If you've ever felt like your EHR is drowning you in data but not actually helping you run your business, this conversation will hit home. Dr. Capra explains why reports aren't actionable, how they fail to drive accountability, and what today's practices need instead—real-time task delegation and verification systems that work with you, not against you.Listen to the full episode with Dr. Brian Capra: Spotify | AppleFollow Dr. Brian: LinkedInResources:For those interested in building a profitable personal brand in just two hours a week, check out Dr. Lauryn's new membership group Beyond Brick & Mortar!Grab Lauryn's free “Sexy Niche Checklist” from her website.Sign up for the Weekly Slay newsletter!Follow She Slays and Dr. Lauryn: Instagram | X | LinkedIn | FacebookSign up here to receive our monthly associate job postings email.

A conversation with Linda MacomberWe need a healthcare renaissance. AI could lead us there.Here to share her optimism and enthusiasm for AI as a new frontier in healthcare, is Linda Macomber.As a digital health expert with over 30 years of experience in health informatics and technology-driven healthcare solutions, Linda is best placed for informing us on the potential AI holds for improving patient experiences and optimising health outcomes.——We spoke about how Linda became interested in the intersection of healthcare and technology, the distrust some doctors feel toward AI, the numerous ways AI could transform data, the EHR and health outcomes, the democratization of health tech, and her education platform Renaissance.Health. Check out Linda's website Renaissance.Health here: https://health-it-sim-lab.weebly.com/ Follow me on Instagram and Facebook @ericfethkemd and checkout my website at www.EricFethkeMD.com. My brand new book, The Privilege of Caring, is out now on Amazon! https://www.amazon.com/dp/B0CP6H6QN4

Revenue cycle disruptions during EHR installs can lead to massive timely filing losses. In this episode, Tadd Miller shares how his team built practical safety nets to stop revenue leakage before it started.Brought to you by www.infinx.com

Rackspace Technology leverages decades of experience and a cloud-first approach to help healthcare organizations optimize costs, drive transformation, and enhance security. In this episode, PV SubbaRao, Senior Vice President of Global Healthcare and Life Sciences at Rackspace Technology, shares how his organization partners with key healthcare sectors to drive innovation. He discusses Rackspace's evolution from early internet hosting to leading cloud solutions that optimize costs and enhance efficiency. PV highlights how the company supports EHR implementations, data center transformations, and security improvements, helping health systems achieve 18-25% savings. He also explores the future of healthcare technology, emphasizing AI, quantum computing, and extended reality as key drivers of personalized medicine and data-driven value. Join us and learn how Rackspace's specialized healthcare team can help your organization transform and scale for the future! Resources: Connect with and follow PV SubbaRao on LinkedIn. Learn more about Rackspace Technology on their LinkedIn and website.

The Trump administration issued its first major budget document Friday, slashing non-defense discretionary spending by $163 billion — a 23% reduction from 2025 levels — and boosting defense spending by 13%. A fact sheet released by OMB references the administration's targeting of “woke” programs and “weaponized” government. One area that would see a significant boost under the budget is the Department of Veterans Affairs' electronic health record modernization program. The EHRM, whose perpetually plagued rollout has been chronicled in congressional testimony and in various watchdog reports, would be provided with a $2.17 billion funding increase in President Donald Trump's budget, per a summary document released Friday. The VA announced in March that it will have implemented the EHR in 13 facilities by 2026, with the possibility of deployment at all VA health systems as early as 2031. That followed a decision in 2023 to pause the system's implementation to renegotiate the contract with its developer Oracle Cerner and account for safety concerns. Friday's budget summary claimed the VA's EHRM rollout “had stalled under the Biden administration” but is a “top priority effort” for Secretary Doug Collins. The Technology Modernization Fund is shifting its funding model to prioritize the full repayment of new “high-impact” investments across the federal government, the General Services Administration said Friday. GSA's press release said the “strategic” change would provide a “streamlined path to modernization” for agencies by “combining upfront capital with specialized advisory services.” The agency said this “enhanced payment model” was pursued with strengthened longevity for projects in mind. Acting GSA Administrator Stephen Ehikian said in a release that “By ensuring full repayment of our investments, the TMF sends a clear message to federal agencies: focus on high-impact, high-return modernization efforts. These investments not only replace outdated systems but also streamline critical operations ultimately improving services for government employees and delivering greater value to taxpayers.” The Daily Scoop Podcast is available every Monday-Friday afternoon. If you want to hear more of the latest from Washington, subscribe to The Daily Scoop Podcast  on Apple Podcasts, Soundcloud, Spotify and YouTube.

In this episode, Yaa Kumah-Crystal, MD, MPH, MS, Associate Professor of Biomedical Informatics and Pediatric Endocrinology at Vanderbilt University Medical Center (VUMC), discusses the potential of AI and voice technology in improving patient care and medical education. She also explores the challenges of interoperability and the potential for more at-home care and patient insights. Dr. Kumah-Crystal talks about the evolution of Electronic Health Records (EHRs) and outlines three phases of EHR development: paper-based, classic digital entry, and the current generative AI era. She highlights significant advancements in ambient documentation workflows, which allow clinicians—especially in pediatrics, where communication is nuanced—to focus more on patients while AI handles note-taking. She shares her vision for fully integrated, voice-based conversational interfaces in EHRs that enhance both clinician satisfaction and patient engagement. Drawing from her experience as a pediatric endocrinologist and her work with Epic as the EHR vendor, she discusses implementing new workflows like Ambience and exploring additional patient communication methods. Dr. Kumah-Crystal also emphasizes the importance of pilot testing, clearly defined ROI metrics, and close collaboration with vendors to drive innovation. She believes AI will be a critical enabler for better outcomes in pediatric care and beyond.

Send us a textGuest: Lance Alston, Director of IT, Nathan Littauer Hospital and Nursing Home Host: Vik PatelOn this episode, Vik welcomes Lance Alston, Director of IT at Nathan Littauer Hospital and Nursing Home, for a candid conversation on leading with resilience, trust, and innovation in a resource-constrained healthcare environment.Lance shares how he's successfully navigating the “do more with less” challenge, emphasizing the importance of trust — both within his team and with external partners. While vendor partnerships can be highly beneficial, Lance acknowledges they often require a culture shift. At Nathan Littauer, he's worked to foster the right mindset and build trust with carefully chosen partners to reduce organizational risk, especially around key personnel dependencies.The conversation also touches on leadership and well-being. Lance and Vik explore the importance of work-life balance in healthcare IT, a field often plagued by burnout. Lance emphasizes leading by example and ensuring team members feel supported in taking time off. This culture shift is backed by the full C-suite, including the CEO, who recognize that employee morale and well-being are essential for long-term success.From there, the discussion transitions into more technical territory, including the organization's current and future AI strategy. Lance highlights how having an enthusiastic and forward-thinking CMIO has been instrumental in exploring AI solutions that support clinical decision-making. Together, they're laying the foundation for a future where AI becomes a practical, integrated tool — not just a buzzword.Vik also introduces Tido CortexAI, an AI-ready data lake that transforms EHR, clinical, and operational data into clean, normalized, and interoperable insights. Whether it's for predictive modeling, automation, or real-time trends, CortexAI provides the data foundation healthcare organizations need to make meaningful use of AI.Finally, Lance offers insights into the importance of open communication across departments — even when the answer isn't immediately clear. “It's okay to say, ‘I'm not sure yet, but I'm working on a solution,'” he says. Fostering transparency, accessibility, and continuous communication is key. Because no matter how advanced the technology, without the right strategy and human connection, it won't deliver its full value.Closing thoughts from Lance: At the end of the day, IT is still IT — even in the age of AI. What truly makes a difference is effective communication, strong relationships, and trust. Especially when you're tasked with doing more with less, those human elements are essential.Support the showListen to all This Week in Health Tech episodesVik Patel - LinkedInTido Inc. - WebsiteTido Inc. - LinkedIn

Dr. Vinay Vaidya, Phoenix Children's Hospital's CMIO and Dr. Wendy Bernatavicius, division chief, explain how collaboration improved patient care by surfacing EHR data in dashboards that clinicians helped build.

Physician executive Grace E. Terrell discusses her article, "Physicians must innovate and focus on medicine's core, not chores." She introduces the concept of "core vs. chore," urging health care workers to distinguish essential patient care duties from the administrative tasks that often dominate their time, exemplified by an incident where staff prioritized EHR procedures over immediate patient needs. Grace highlights how poorly designed technology like EHRs, regulatory demands, and inefficient workflows contribute significantly to physician burnout, administrative burden, and information chaos, noting that physicians spend nearly twice as much time on EHR and desk work as they do on direct patient care. The conversation explores solutions such as redesigning care delivery models to delegate non-essential tasks, utilizing technology-enabled support teams, and enabling clinicians to practice at the top of their license, ultimately aiming to recenter health care on its core mission, reduce costs, and improve both patient and clinician experiences. Our presenting sponsor is Microsoft Dragon Copilot. Microsoft Dragon Copilot, your AI assistant for clinical workflow, is transforming how clinicians work. Now you can streamline and customize documentation, surface information right at the point of care, and automate tasks with just a click. Part of Microsoft Cloud for Healthcare, Dragon Copilot offers an extensible AI workspace and a single, integrated platform to help unlock new levels of efficiency. Plus, it's backed by a proven track record and decades of clinical expertise—and it's built on a foundation of trust. It's time to ease your administrative burdens and stay focused on what matters most with Dragon Copilot, your AI assistant for clinical workflow. VISIT SPONSOR → https://aka.ms/kevinmd SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

April 30, 2025: Davin Juckett, Head of Experis Health Solutions, discusses Experis' three decades of solving problems and supporting hospitals. What makes their team's remarkable retention rate—fewer than five voluntary departures in five years—such a critical differentiator in today's talent-starved healthcare landscape? Davin reveals how Experis is tackling healthcare's most pressing challenges through AI-powered clinical service desks, cloud security solutions, and supply chain optimization, while also managing massive EHR go-lives with thousands of at-the-elbow resources. As healthcare organizations struggle with clinician shortages, margin compression, and complex M&A integrations, what entrepreneurial approaches is Experis developing to help CIOs navigate these turbulent waters? Key Points: 01:24 History of Experis Health Solutions 02:49 Current Service Offerings 06:26 Unique Challenges and Solutions 11:03 Future Directions 12:21 Lightning Round X: This Week Health LinkedIn: This Week Health Donate: Alex's Lemonade Stand: Foundation for Childhood Cancer

Today I'm joined by Ajay Prasad, founder of Repugen—a reputation management company that helps healthcare providers strengthen their digital presence by collecting and managing patient reviews.In this episode, Ajay and I explore how online reviews can help you build trust, attract more patients, and even increase the value of your practice if you decide to sell later on.We cover lots of practical insights, including:The best time to ask for reviews—and how to ask in a way that feels naturalWhat to do about negative reviews (and whether they're really as damaging as they seem)Why it's so important for your online reputation to reflect the quality of care you actually provideWhat many practitioners get wrong about reputation managementAnd a reminder that most patients won't leave a review unless they're asked—but many are happy to say yes when promptedIf it's been a while since you asked for reviews, this episode is your reminder. Social proof matters, and reviews are one of the most powerful ways to build it.So if you're in a country where healthcare providers can ask for reviews—because I know that's not the case everywhere—then I hope this conversation encourages you to start asking regularly.SHOW NOTES:Digital reputation management: Repugen.comPatient acquisition and comprehensive digital marketing: GMRwebteam.com

Welcome solo and group practice owners! We are Liath Dalton and Evan Dumas, your co-hosts of Group Practice Tech. In our latest episode, we share what you need to know about syncing your EHR calendar with HIPAA in mind. We cover: Managing confidentiality and availability of data Having redundancies for worst case scenarios Types of calendar syncs and their benefits and drawbacks  How to sync your calendars in a HIPAA-appropriate way Listen here: https://personcenteredtech.com/group/podcast/ For more, visit our website. PCT Resources PCT's free Group Practice Service Selection Workbook & Worksheets  -- support for selecting HIPAA-secure, effective, and economical services to meet your practice's functionality and operational needs optional accompanying on-demand CE training: Designing a Group Practice's Tech Setup for Success: Effectiveness, HIPAA Compliance, Client Safety, and Efficiency (1 legal-ethical CE credit hour) Group Practice Care Premium weekly (live & recorded) direct support & consultation service, Group Practice Office Hours -- including monthly session with therapist attorney Eric Ström, JD PhD LMHC + assignable staff HIPAA Security Awareness: Bring Your Own Device training + access to Device Security Center with step-by-step device-specific tutorials & registration forms for securing and documenting all personally owned & practice-provided devices (for *all* team members at no per-person cost) +  assignable staff HIPAA Security Awareness: Remote Workspaces training for all team members + access to Remote Workspace Center with step-by-step tutorials & registration forms for securing and documenting Remote Workspaces (for *all* team members at no per-person cost) + more HIPAA Risk Analysis & Risk Mitigation Planning service for mental health group practices -- care for your practice using our supportive, shame-free risk analysis and mitigation planning service. You'll have your Risk Analysis done within 2 hours, performed by a PCT consultant, using a tool built specifically for mental health group practice, and a mitigation checklist to help you reduce your risks.

Brian Drozdowicz, Senior VP and General Manager for Acute and Payer at PointClickCare, provides a platform using predictive analytics and AI for data sharing and collaboration across healthcare stakeholders. Interoperability has been an ongoing challenge due to the lack of standards and clear governance to support data sharing. The shift to value-based care drives the need for more access to patient data to improve patient outcomes, facilitate care transitions, and reduce readmissions and costs.   Brian explains, "PointClickCare has been a player in the market for quite some time. We're best known for the market-leading senior care EHR that we've had in market for 20-plus years. I run a business unit that sits by the side of that. We refer to that as the acute and payer business. And ultimately, this additional business and value proposition to the market operates the largest care collaboration network, sharing healthcare data across all the different stakeholders, hospitals, health plans, ambulatory clinics, community providers, and connecting is our core business. So we're ultimately in the business of sharing data and doing that safely, securely in a trusted way." "There are a lot of ways of driving adoption and sharing data at scale. I'd call out a couple of key areas in which we've seen a lot of progress in recent years. First is having well-established technology standards that safely and securely transmit that data. Number Two is having to share that data. So, otherwise, it's a bunch of data flowing back and forth just for the sake of data. And that doesn't solve anything with value-based care. Putting a set of guardrails in place requires providers and payers to work together with this data." #PointClickCare #HealthcareData #Interoperability #MedAI #DataSilos #ValueBasedCare #VBC  pointclickcare.com Download the transcript here

Brian Drozdowicz, Senior VP and General Manager for Acute and Payer at PointClickCare, provides a platform using predictive analytics and AI for data sharing and collaboration across healthcare stakeholders. Interoperability has been an ongoing challenge due to the lack of standards and clear governance to support data sharing. The shift to value-based care drives the need for more access to patient data to improve patient outcomes, facilitate care transitions, and reduce readmissions and costs.   Brian explains, "PointClickCare has been a player in the market for quite some time. We're best known for the market-leading senior care EHR that we've had in market for 20-plus years. I run a business unit that sits by the side of that. We refer to that as the acute and payer business. And ultimately, this additional business and value proposition to the market operates the largest care collaboration network, sharing healthcare data across all the different stakeholders, hospitals, health plans, ambulatory clinics, community providers, and connecting is our core business. So we're ultimately in the business of sharing data and doing that safely, securely in a trusted way." "There are a lot of ways of driving adoption and sharing data at scale. I'd call out a couple of key areas in which we've seen a lot of progress in recent years. First is having well-established technology standards that safely and securely transmit that data. Number Two is having to share that data. So, otherwise, it's a bunch of data flowing back and forth just for the sake of data. And that doesn't solve anything with value-based care. Putting a set of guardrails in place requires providers and payers to work together with this data." #PointClickCare #HealthcareData #Interoperability #MedAI #DataSilos #ValueBasedCare #VBC  pointclickcare.com Listen to the podcast here

In this episode, Charulata Nevatia, Product Director at Infinx, explains how AI-driven document capture supports automation in prior authorization, order creation, and EHR workflows. Learn how intelligent agents process faxes, eliminate duplicates, and integrate with systems using APIs or RPA.

What if your health tech solution is built on biased data, and you don't even know it?On this episode, I sat down with Beverly Miner of Consensus Cloud Solutions live from the floor of VIVE to talk about one of the most overlooked drivers of healthcare inequity—unstructured data. From missed medications to tragic delays in care, we walk through what happens when critical patient information is locked in PDFs, never reaches the right provider, and gets left out of the systems we rely on to make decisions.You'll hear what Beverly's team is doing to:Eliminate the need for costly EHR overhauls with cloud fax + data extractionSolve real problems like discharge delays, referral breakdowns, and prior auth lagImprove clinical workflow without asking care teams to learn new tech or platformsAddress health equity by first solving tech equity in underserved marketsOne of Beverly's own family members died waiting for a prior authorization. That's what drives her. This episode isn't about buzzwords—it's about fixing the backend issues that block care from reaching people who need it most.If you're a founder building in health tech, it's time to stop creating tools that live in silos or pile more work on your end users. Ask:Is your tech actually making it easier to deliver care—or just easier to sell a demo?Key Talking Points:

Seth Hain, SVP of R&D at Epic, joins a16z Bio + Health general partner Julie Yoo to explore technology in healthcare. Reflecting on over two decades of industry shifts, Seth shares how Epic has transitioned from enabling integrated systems within health systems to driving cross-ecosystem collaboration and rapid innovations like generative AI.They also discuss orchestration of patient care across diverse settings, the transformative impact of AI on clinical workflows, and whether "electronic health record" is really the best term for clinical record-keeping software. Learn more about a16z Bio+HealthLearn more about & Subscribe to Raising HealthFind a16z Bio+Health on LinkedInFind a16z Bio+Health on X

In this episode, Dr. Kemberly Blackledge, Chief Revenue Cycle Officer at Nashville General Hospital, shares insights into how the hospital is advancing health equity through innovative programs, EHR modernization, and strategic partnerships—while tackling challenges like inflation, funding cuts, and federal regulation to ensure long-term sustainability.

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to outcomesrocket.com Staying nimble and adaptable to emerging technologies is crucial for success in the rapidly evolving healthcare technology landscape.  In this episode, Pat Williams, co-founder and CEO of iScribeHealth, discusses the company's journey as a generative AI documentation company, detailing its evolution through three distinct "Netflix seasons." He highlights how iScribe transitioned from a mobile app focused on EHR integration to offering human-based virtual scribing and ultimately embracing fully automated AI-powered documentation. Pat emphasizes the importance of understanding customer needs and the nuances of clinical settings, particularly within the ambulatory care sector, to deliver effective solutions. Finally, he touches upon the focus needed in the industry, the challenges of physician acceptance, and iScribe's plans to expand its platform to include autonomous coding, denial management, and prior authorization impact. Tune in and learn how iScribe is leveraging its history and expertise to transform healthcare documentation! Resources:  Connect and follow Pat Williams on LinkedIn. Learn more about iScribeHealth on their LinkedIn and website. Buy Gino Wickman's book Traction here. Fast Track Your Business Growth: Outcomes Rocket is a full-service marketing agency focused on helping healthcare organizations like yours maximize your impact and accelerate growth. Learn more at outcomesrocket.com